Drug Type Small molecule drug |
Synonyms Compound 10(Université Côte d'Azur/Roca) |
Target |
Action antagonists |
Mechanism CXCR1 antagonists(C-X-C motif chemokine receptor 1 antagonists), CXCR2 antagonists(C-X-C motif chemokine receptor 2 antagonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC14H8Cl2N4O3S |
InChIKeyFCQTYYYNDNQUIQ-UHFFFAOYSA-N |
CAS Registry2415653-55-1 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Preclinical | France | 03 Apr 2024 | |
Neoplasms | Preclinical | France | 03 Apr 2024 |